Cite
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.
MLA
Weng, Guangyang, et al. “Hypomethylating Agents plus Modified Priming Regimens Compared with Venetoclax-Based Regimens Based on Molecular Characteristics for Newly Diagnosed Patients with Acute Myeloid Leukemia: A Multi-Center Cohort Study.” Annals of Hematology, vol. 102, no. 12, Dec. 2023, pp. 3369–81. EBSCOhost, https://doi.org/10.1007/s00277-023-05452-7.
APA
Weng, G., Huang, J., He, X., Xue, T., Yang, L., Zhang, Y., Yu, G., Sun, Z., Lin, D., Deng, L., Liang, X., Xiao, J., Zhang, H., Guo, Z., Jin, H., Liu, Q., & Du, X. (2023). Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study. Annals of Hematology, 102(12), 3369–3381. https://doi.org/10.1007/s00277-023-05452-7
Chicago
Weng, Guangyang, Jingya Huang, Xin He, Tingting Xue, Linlin Yang, Yu Zhang, Guopan Yu, et al. 2023. “Hypomethylating Agents plus Modified Priming Regimens Compared with Venetoclax-Based Regimens Based on Molecular Characteristics for Newly Diagnosed Patients with Acute Myeloid Leukemia: A Multi-Center Cohort Study.” Annals of Hematology 102 (12): 3369–81. doi:10.1007/s00277-023-05452-7.